Diabetes Mellitus, Type 2: all 9,590 studies
Page 68 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Lifestyle Modification for Type 2 Diabetes Involving Reduction of After-meal Blood Glucose ElevationsCompletedNCT02432391Not applicable
- Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus AlogliptinStatus unknownNCT02426294Phase 4
- Multi-Center Study Comparing Efficacy and Safety of Frequently Modified Insulin TherapyCompletedNCT02424500Not applicable
- Three-dimensional Measurements of Diabetic Foot UlcersCompletedNCT02423850
- Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 DiabetesCompletedNCT02423434
- Study to Weigh the Effect of Exercise Training on BONE (SWEET-BONE) Quality and Strength in Type 2 DiabetesCompletedNCT02421393Not applicable
- Effects of Dapagliflozin on the Incretin Sensitivity of the Pancreatic Beta CellCompletedNCT02420392Not applicable
- A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes MellitusCompletedNCT02419859Not applicable
- Lifestyle and Glucose Lowering Medication in T2DMCompletedNCT02417012Not applicable
- The Role of Gut Hormones and Hepcidin in Type 2 Diabetes MellitusCompletedNCT02413762
- Evaluation of Duodenal Mucosal Resurfacing in Subjects With Type 2 DiabetesCompletedNCT02413567Not applicable
- Effects of Replacing Diet Beverages With Water on Weight Loss and Plasma Glucose Control in Type 2 DiabetesCompletedNCT02412774Not applicable
- Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) PatientsCompletedNCT02411825Phase 1
- Insulin Resistance and Mild Cognitive Impairment (IRMCI) StudyTerminatedNCT02409238Phase 4
- Add Glucokinase Activator to Target A1cCompletedNCT02405260Phase 2
- Comparison of a Plant Protein Diet to a Animal Protein Diet Emphasized in Type 2 DiabeticsCompletedNCT02402985Not applicable
- Effects of Linagliptin in Addition to Empagliflozin on Islet Cell PhysiologyCompletedNCT02401880Phase 4
- Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus PatientsCompletedNCT02401243Phase 3
- Influence of Regular Exercise and Detraining on Metabolic and Emotional Parameters in Diabetic IndividualsCompletedNCT02400515Not applicable
- Investigating the Safety and Effectiveness of Insulin Degludec in a Real World Population With Type 1 and 2 Diabetes MellitusCompletedNCT02392117
- Relationship Between HbA1c and Chronic Glycemia in Patients With CirrhosisCompletedNCT02389127
- Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 DiabetesCompletedNCT02388113Not applicable
- Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM PatientsCompletedNCT02386982Phase 1
- Behavioral Lifestyle Intervention Study (BLIS) in Patients With Type 2 Diabetes in UAE: A Randomized Controlled Trial in Real Life SettingCompletedNCT02386930Not applicable
- Aloe Vera in Chronic Periodontitis With Type 2 Diabetes MellitusCompletedNCT02386020Phase 2/3
- Effects of Low- or High-glycemic Index Diets on Metabolic and Inflammatory Responses in DiabeticsCompletedNCT02383784Not applicable
- Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium ContentCompletedNCT02383238Phase 3
- Effects of Personalized Dietary Advice on Health Status of Diabetes Type 2 PatientsCompletedNCT02381119Not applicable
- Exenatide Once Weekly, Cardiovascular Risk and Type-2 DiabetesCompletedNCT02380521Phase 4
- Dietary Calcium Supplementation, Gut Permeability and Microbiota in Type 2 DiabeticsCompletedNCT02377076Not applicable
- Pre-Visit Prioritization for Complex Patients With DiabetesCompletedNCT02375932Not applicable
- A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male VolunteersCompletedNCT02375139Phase 1
- Sophia Step Study - a Behaviour Change Program on Physical Activity in Persons With Pre- and Type 2 DiabetesCompletedNCT02374788Not applicable
- Fatty Acid Regulation of Platelet Function in DiabetesCompletedNCT02373332
- Safety, Tolerability and PK of Imeglimin in Japanese VolunteersCompletedNCT02373150Phase 1
- Mechanistic Study of the Systolic Blood Pressure Lowering Effect of Dapagliflozin in Type 2 DiabetesStatus unknownNCT02372955Phase 4
- SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2CompletedNCT02371239Not applicable
- Evaluation of an mHealth Behavioural Intervention for the Self-Management for Type 2 DiabetesTerminatedNCT02370719Not applicable
- Role of Endoplasmic Reticulum Stress in the Pathophysiology of Type 2 DiabetesStatus unknownNCT02368704
- Effects of Physical Exercise on Blood Glucose and Pain From the Musculoskeletal System in Patients With Type 2 DiabetesCompletedNCT02366416Not applicable
- The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus PatientsStatus unknownNCT02366377Phase 1
- The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus PatientsStatus unknownNCT02366351Phase 1
- Clinical Study to Compare Various Dosing and Titration Guidelines of Insulin Delivered Via V-Go ® in Patients With Type 2 Diabetes Initiating Basal Bolus Therapy in Primary Care OfficesStatus unknownNCT02361489Phase 4
- The PK/PD Study of Multiple Dose of SHR3824 in Healthy VolunteersCompletedNCT02361138Phase 1
- The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin HormonesCompletedNCT02360878
- Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s DiseaseCompletedNCT02360527
- Evaluation of the Effect of Pulsatile Cuts Stendo3 on Vascular Function Patients With Diabetes Type 2CompletedNCT02359461Not applicable
- A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT02358096Phase 2
- The PK/PD Study of Single Dose of SHR3824 in Healthy VolunteersCompletedNCT02356224Phase 1
- Non-inteRvEntional Study to Observe rAtionaLe to Select add-on TherapY for Type 2 Diabetes Inadequately Controlled With Metformin.CompletedNCT02355145
- HIIE and Abdominal Fat Mass in DT2 Postmenopausal WomenStatus unknownNCT02352246Not applicable
- Novel Type 2 Diabetes Mellitus Preventive TherapiesCompletedNCT02351323Phase 1
- The Effect of Shear- Force at the Skin in Patients With Diabetes MellitusStatus unknownNCT02348294Not applicable
- Differential Characteristics of Neuropathy in Type 2 Diabetics With and Without Lower Extremity WoundsWithdrawnNCT02347709
- Impact of Sleep and Meal Timing on Food Intake RegulationCompletedNCT02347020Not applicable
- Fecal Microbiota Transplantation for Diabetes Mellitus Type II in Obese PatientsStatus unknownNCT02346669Phase 2
- Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes MellitusCompletedNCT02346344
- Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus PatientsCompletedNCT02346175Phase 1
- Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure PatientsStatus unknownNCT02344641Not applicable
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 DiabetesStatus unknownNCT02344186Phase 4
- Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With MetforminCompletedNCT02343926Phase 3
- The Effect of Whey Protein Consumed as a Pre-meal on Postprandial Lipemia in Healthy and Subjects With Type 2 DiabetesCompletedNCT02343471Not applicable
- E-coaching for Type 2 DiabetesCompletedNCT02343107Not applicable
- Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose HomeostasisCompletedNCT02342834Not applicable
- Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 DiabetesCompletedNCT02341690Not applicable
- Time Efficient Exercise in Type 2 DiabetesCompletedNCT02340260Not applicable
- Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination TherapyCompletedNCT02338921Phase 4
- Glucose Variability Pilot Study for the Abbott Sensor Based Glucose Monitoring System-ProfessionalCompletedNCT02336945
- Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)TerminatedNCT02333851Phase 4
- Investigation of the Effect of 8-week Controlled High Intense Interval Training in Type 2 Diabetic PatientsCompletedNCT02333734Not applicable
- Effect of BAriatric Surgery Versus Optimal Medical Therapy on Cardiovascular Health and Atherosclerosis in Obese, Type II Diabetic PatientsStatus unknownNCT02331420Not applicable
- Affect of Incentive Strategy on the Adherence to Medication Among Patients With Type 2 DiabetesStatus unknownNCT02330484Not applicable
- Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 DiabetesCompletedNCT02328599
- Novel Biomarker for Development of T2DCompletedNCT02326129
- An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes MellitusTerminatedNCT02324491Phase 2
- The EMPATHy Toolkit: Helping Diabetes Patients Overcome Barriers to Medication AdherenceCompletedNCT02324036Early Phase 1
- DISCOVERing Treatment Reality of Type 2 Diabetes in Real World SettingsCompletedNCT02322762
- RCT Evaluating Effects of Cosmos Caudatus (Ulam Raja) in T2DM PatientsCompletedNCT02322268Not applicable
- Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)CompletedNCT02321878
- Interval-training in Type 2 DiabeticsCompletedNCT02320526Not applicable
- Supporting Practices to Adopt Registry-Based CareStatus unknownNCT02318108Not applicable
- Adult Subjects With Uncontrolled Type 2 DiabetesCompletedNCT02317796Phase 2
- Investigation for Clinical Efficacy and Safety of Ipragliflozin 50mg and 100mg on Type II DiabetesCompletedNCT02317484
- Purified Anthocyanins Supplementation in Type 2 Diabetes MellitusCompletedNCT02317211Early Phase 1
- Physical Exercise Prescription With PEdometeR in General Practice for Patients With Cardiovascular Risk Factors - PEPPERCompletedNCT02317003Not applicable
- The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI StudyCompletedNCT02316821Phase 2
- Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)CompletedNCT02316054
- Combining Saxagliptin and Acarbose to Improve Postprandial Glycaemia in Type 2 DiabetesCompletedNCT02315495Phase 3
- Patient-Centered Smartphone-Based Diabetes CareCompletedNCT02313363Early Phase 1
- The Sapienza University Mortality and Morbidity Events Rate (SUMMER) Study in DiabetesCompletedNCT02311244
- Mechanisms of Endothelial Dysfunction in Type 2 DiabetesCompletedNCT02311075Not applicable
- TODAY2 Phase 2 Follow-upCompletedNCT02310724
- IL-1RA, Acute Exercise, and Beta-cell FunctionWithdrawnNCT02310009Not applicable
- The Effect of Vinegar on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Tolerance or Type 2 DiabetesCompletedNCT02309424Not applicable
- A Survey on Low Blod Sugar Among Insulin-treated Patients With DiabetesCompletedNCT02306681
- Efficacy and Safety of Prescription Omega-3 Fatty Acid Added to Stable Statin Therapy in Patients With Type 2 Diabetes and HypertriglyceridemiaCompletedNCT02305355Phase 4
- Hartmann's Solution and Normal Saline in Type II Diabetes PatientsWithdrawnNCT02305199Not applicable
- Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell FunctionCompletedNCT02304081Phase 4
- Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesCompletedNCT02303730Phase 4
- Mesenchymal Stem Cells to Treat Type 2 DiabetesCompletedNCT02302599Phase 2